The Paris-Saclay Cancer Cluster (PSCC) is pleased to announce the recent arrival of Thierry Jean as Director of Strategy.
Thierry holds a PhD in Biology and Physiology from the University of Paris-Saclay and a three-year post-doctoral fellowship at the NIH (National Cancer Institute).
A CNRS researcher and founder of Cerep, a world leader in in vitro drug profiling, Thierry led the company for 25 years. He also led MImAbs, a company dedicated to the discovery of therapeutic antibodies against cancer, for three years.
His experience and strategic vision will be valuable assets to the PSCC in its mission to accelerate innovation against cancer.
Commentaires